Skip to main content
main-content

12-10-2018 | Multiple sclerosis | Video

ECTRIMS 2018: Real-world data support early treatment initiation in relapsing-remitting MS patients

Pietro Iaffaldano shares his real-world findings from the Big Multiple Sclerosis Data Network showing an optimal time to treatment initiation of 6 months in patients with relapsing-remitting multiple sclerosis (1:51).

Funding for this video was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland.

The Big Multiple Sclerosis Data Network project was supported by Biogen International (Zug, Switzerland).

image credits